Work

A Flow Cytometric Clonogenic Assay Reveals the Single-Cell Potency of Doxorubicin

Year: 2015

Type: article

Source: Journal of Pharmaceutical Sciences

DOI: 10.1002/jps.24631

Authors: Katie F. Maass, Chethana Kulkarni, Mohiuddin A. Quadir, Paula T. Hammond, Alison M. Betts, Karl Dane Wittrup

Institutions: Koch Institute for Integrative Cancer Research At MIT, Massachusetts Institute of Technology, Pfizer (United States)

Language: English

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Science Foundation, Pfizer, Hertz Foundation, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, National Cancer Institute

Awards: Foundations of Pretargeted Radioimmunotherapy, Engineered Antibody EGFR Antagonist Cancer Therapeutics, Localizing Immunotherapy to Improve Therapeutic Index, Cancer Center Support (Core) Grant

OpenAlex ID: W1831962323

FWCI: 0.669

Cites: 44

Cited by: 14

Related to: 10